Gadobutrol (Gadovist, BAY86-4875)
Gadobutrol (Gadovist, BAY86-4875) is a pharmaceutical drug with 8 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 8 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
5
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
8 of 8 finished
0.0%
0 ended early
0
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Gadobutrol Enhanced MRA of the Supra-aortic Vessels
Safety of Gadovist in Renally Impaired Patients
Gadobutrol Enhanced MRA of the Renal Arteries
GARDIAN, Gadovist in Routine Diagnostic Magnetic Resonance Imaging Administration in Non-selected Patients
Gadobutrol Magnevist-controlled Body Study
Clinical Trials (8)
Gadobutrol Enhanced MRA of the Supra-aortic Vessels
Safety of Gadovist in Renally Impaired Patients
Gadobutrol Enhanced MRA of the Renal Arteries
GARDIAN, Gadovist in Routine Diagnostic Magnetic Resonance Imaging Administration in Non-selected Patients
Gadobutrol Magnevist-controlled Body Study
Safety and Efficacy of Gadobutrol 1.0 Molar in Japanese Subjects for CNS Imaging
Patient Characteristics in Daily Radiological Practice of Gadovist® Application (PATRON)
Observational Study on the Safety and Tolerability of Gadobutrol (Gadovist) Among Filipino Patients in Magnetic Resonance Imaging
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8